| Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma L De Mattos-Arruda, R Mayor, CKY Ng, B Weigelt, F Martínez-Ricarte, ... Nature communications 6 (1), 8839, 2015 | 739 | 2015 |
| Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk TA King, M Pilewskie, S Muhsen, S Patil, SK Mautner, A Park, S Oskar, ... Journal of clinical oncology 33 (33), 3945, 2015 | 196 | 2015 |
| The genomic landscape of male breast cancers S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ... Clinical Cancer Research 22 (16), 4045-4056, 2016 | 151 | 2016 |
| Dynamic retention of Ero1α and Ero1β in the endoplasmic reticulum by interactions with PDI and ERp44 M Otsu, G Bertoli, C Fagioli, E Guerini-Rocco, S Nerini-Molteni, E Ruffato, ... Antioxidants & redox signaling 8 (3-4), 274-282, 2006 | 118 | 2006 |
| Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and … SK Mahil, N Wilson, N Dand, NJ Reynolds, CEM Griffiths, R Emsley, ... British Journal of Dermatology 182 (5), 1158-1166, 2020 | 117 | 2020 |
| Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions M Atienza-Amores, E Guerini-Rocco, RA Soslow, KJ Park, B Weigelt Gynecologic oncology 134 (2), 410-418, 2014 | 111 | 2014 |
| Multicenter comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) assays to test PD-L1 expression for NSCLC patients to be treated with immune checkpoint inhibitors A Marchetti, M Barberis, R Franco, G De Luca, MV Pace, S Staibano, ... Journal of Thoracic Oncology 12 (11), 1654-1663, 2017 | 105 | 2017 |
| PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine? N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, EG Rocco, ... Genes 11 (7), 719, 2020 | 92 | 2020 |
| E‐cadherin deregulation in breast cancer G Corso, J Figueiredo, SP De Angelis, F Corso, A Girardi, J Pereira, ... Journal of Cellular and Molecular Medicine 24 (11), 5930-5936, 2020 | 86 | 2020 |
| Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer N Fusco, FC Geyer, MR De Filippo, LG Martelotto, CKY Ng, S Piscuoglio, ... Modern Pathology 29 (11), 1292-1305, 2016 | 85 | 2016 |
| HER2 low, ultra-low, and novel complementary biomarkers: expanding the spectrum of HER2 positivity in breast cancer K Venetis, E Crimini, E Sajjadi, C Corti, E Guerini-Rocco, G Viale, ... Frontiers in molecular biosciences 9, 834651, 2022 | 78 | 2022 |
| HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions N Fusco, EG Rocco, C Del Conte, C Pellegrini, G Bulfamante, F Di Nuovo, ... Modern Pathology 26 (6), 816-824, 2013 | 76 | 2013 |
| Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment A Passaro, E Guerini-Rocco, A Pochesci, D Vacirca, G Spitaleri, ... Pharmacological research 117, 406-415, 2017 | 72 | 2017 |
| The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study E Guerini‐Rocco, Z Hodi, S Piscuoglio, CKY Ng, EA Rakha, ... The Journal of pathology 237 (2), 166-178, 2015 | 62 | 2015 |
| The genetic landscape of breast carcinomas with neuroendocrine differentiation C Marchiò, FC Geyer, CKY Ng, S Piscuoglio, MR De Filippo, M Cupo, ... The Journal of pathology 241 (3), 405-419, 2017 | 61 | 2017 |
| Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations E Guerini‐Rocco, S Piscuoglio, CKY Ng, FC Geyer, MR De Filippo, ... The Journal of pathology 238 (5), 677-688, 2016 | 60 | 2016 |
| Targeting immune-related biological processes in solid tumors: we do need biomarkers F Pagni, E Guerini-Rocco, AM Schultheis, G Grazia, E Rijavec, M Ghidini, ... International journal of molecular sciences 20 (21), 5452, 2019 | 57 | 2019 |
| PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast Carcinoma RA Sakr, B Weigelt, S Chandarlapaty, VP Andrade, E Guerini-Rocco, ... Clinical Cancer Research 20 (9), 2326-2337, 2014 | 56 | 2014 |
| Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family FC Geyer, SH Berman, C Marchiò, KA Burke, E Guerini-Rocco, ... Modern Pathology 30 (1), 69-84, 2017 | 53 | 2017 |
| SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma E Guerini-Rocco, SV Taormina, D Vacirca, A Ranghiero, A Rappa, ... Journal of Clinical Pathology 73 (11), 754-757, 2020 | 47 | 2020 |
Charlotte K Y NgHumanitas University and University of BernVerified email at unibe.ch
